Cell-Based Therapies for Tissue Fibrosis.

about

Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts TGF-β-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2

P2860

Q57492151-4615A5A1-4A53-4809-B70C-84281E5F7FCC

P2860

Cell-Based Therapies for Tissue Fibrosis.

Item

http://www.wikidata.org/entity/Q42369905

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cell-Based Therapies for Tissue Fibrosis.

@en

Cell-Based Therapies for Tissue Fibrosis.

@nl

type

Item

label

Cell-Based Therapies for Tissue Fibrosis.

@en

Cell-Based Therapies for Tissue Fibrosis.

@nl

prefLabel

Cell-Based Therapies for Tissue Fibrosis.

@en

Cell-Based Therapies for Tissue Fibrosis.

@nl

P1476

Cell-Based Therapies for Tissue Fibrosis.

@en

P2093

Rebecca Lim

http://www.w3.org/2001/XMLSchema#string

William Sievert

http://www.w3.org/2001/XMLSchema#string

P2860

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury

Pro-fibrogenic potential of PDGF-D in liver fibrosis

The chemokine system in diverse forms of macrophage activation and polarization

Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy.

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis.

P304

633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2017.00633

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sharon D. Ricardo

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29033833

http://www.w3.org/2001/XMLSchema#string

P932

5626978

http://www.w3.org/2001/XMLSchema#string

Cell-Based Therapies for Tissue Fibrosis.

about

P2860

P2860

Cell-Based Therapies for Tissue Fibrosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932